Search

everythinglearnresearchcommunity

for

Search:↓

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

Oral mTOR inhibitors often cause skin and hair side effects but usually don't require stopping treatment.

The pandemic changed how often certain skin conditions were diagnosed.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Beau's lines on fingernails might indicate past severe COVID-19 and risk of reinfection.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

More research is needed to understand sex and racial differences in long COVID.

Nursing staff's mental health was affected during the COVID-19 pandemic.

Resident doctors had more facial skin discoloration than medical students during COVID-19.

COVID-19 can cause various skin issues in children, mostly not severe, with chilblain-like lesions being common, especially in adolescents.

Booster doses of Covaxin improve protection against the Omicron variant.

Long-COVID symptoms can last more than a year and change over time.

COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

About 61% of women who had COVID-19 experienced hair loss afterward.

Many patients experienced severe hair loss after COVID-19, especially older adults and women.

A COVID-19 patient had severe and long-lasting skin issues and unusual hair loss.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

Monocytes might be linked to hair loss after COVID-19.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Hospitalized COVID-19 survivors have a higher risk of long-term symptoms and need special care.

Vaccinated healthcare workers rarely experience long COVID-19 symptoms.

Most severe COVID-19 patients in Mexico experienced long-lasting symptoms that worsened their quality of life.

Standardized definitions and better methods are needed to accurately estimate long COVID-19 prevalence.

Almost half of COVID-19 patients in Makkah, Saudi Arabia experienced increased hair loss, especially women and those with chronic diseases.

Post-COVID, many patients experience skin issues like hair loss and herpes reactivation, especially in middle-aged women.

A COVID-19 infected patient with chronic kidney disease experienced worsened kidney function, hair loss, and unexpected wart clearance.

The study concludes that long COVID recovery involves time, various treatments, and a strong patient-provider relationship.